Chimeric Therapeutics Limited has released a press release.
Appointment of Financial Adviser for Strategic Review
Earlier from Chimeric Therapeutics
- CHM announces positive Phase 1/2 data at ASCO
- Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program
- Consolidation/Split - CHM
- Chimeric receives $1.8 M advance on FY26 R&D tax incentive